您要查找的是不是:
- Clinical Study of Advanced Primary Hepatocellular Carcinoma Cells After TACE with use of Portal Vein Perfusion Chemothepary 肝癌经肝动脉化疗栓塞及门静脉持续灌注化疗的临床研究
- portal vein perfusion 门静脉灌注
- Each group were measured portal vein pressure(PVP), mean arterial pressure(MAP) and heart rate(HR), Their blood and livers were colleced for analysis . 各组于治疗结束后测门静脉压力(PVP)、平均动脉压(MAP)、心率(HR);
- Portal-azygous devascularization can maintain PVP and PG in portal vein and do not affect liver function of the control rats but it can damage liver cell in cirrhotic rats. 断流术能维持PVP及门脉血PG水平,对正常大鼠肝功能影响小,但对肝硬变大鼠的肝细胞有损害。
- Objective To explore the therapeutic effect of dual perfusion embolization and chemotherapy via hepatic artery and portal vein( combmation treatment) in the treatment of unresectable PHC. 目的探讨肝动脉、静脉双栓化疗对不能切除的原发性肝癌的治疗作用。
- Strategy of Therapy for Portal Vein Spongiform in Children. 小儿门静脉海绵样变治疗的思路。
- There were no tumor thrombi in the main portal vein. 门静脉主干内未及癌栓。
- Of or relating to the portal vein or the portal system. 门静脉门静脉的,门静脉系统的,与门静脉系统有关的
- Objective To explore the therapeutic effect of dual perfusion embolization and chemotherapy via hepatic artery and portal vein ( combmation treatment) in the treatment of unresectable PHC. 目的探讨肝动脉、静脉双栓化疗对不能切除的原发性肝癌的治疗作用。
- METHODS Portal vein cannulation and perfusion combined with collagenase digestion were used to isolate pig pup hepatocytes.They were then cultured and passaged into the conditioned medium. 方法 用门静脉插管原位灌注结合胶原酶消化法分离乳猪肝细胞;应用条件培养基对其进行体外培养;观察其形态、增殖、分化和功能等方面的变化.
- The color flow of the portal vein revealed no color,red,mosaic or filling defect. 结果 :pv内CDFI可显示本色、红色、混色或充盈缺损。
- MRI also suggested hepatic metastasis in 4 cases, portal vein invasion in 7 cases. MRI发现 4例肝转移 ,7例门静脉主干或分支受累。
- Results The main portal vein appearance was accordant with 3D CE MRP and direct x-ray portography in all cases. 结果3D CE mrp和直接门静脉造影显示门静脉主干的结果完全一致。
- Preliminary survival observation on purcutaneous portal vein chronomodulated chemotherapy on treatment of liver cancer. 肝癌经皮门静脉时辰化疗生存期的初步观察。
- Samples of blood were collected from the radial artery, portal vein (PV) and hepatic vein (HV), in up to 120 minutes postreperfusion. 再灌注后120分钟后从桡动脉、门静脉和肝静脉采血液样本。
- The portal vein injection of LUF in the rats is simple procedure and the results are reliable. 活体碘油门静脉灌注方法简单易行,结果真实可靠;
- Compared with 30% PH,70% PH could obviously increase hepatocyte transgenic efficiency via rat portal vein. 与 30%25肝部分切除术相比 ,70%25切肝可显著提高大鼠肝细胞门静脉途径转基因的效率
- DST,DSSL and DSBM can induce the specific tolerance by the way of portal vein infusion. 发现供者特异性输血(DST)、供者特异性脾细胞(DSSL)和供者特异性骨髓细胞(DSBM)能诱导受体对供体移植物产生免疫耐受。
- Methods 108 3D DCE MRA and 10 2D DCE MRA were performed and compared in visulization of the right Portal vein branches. 方法门静脉和肝脏静脉系统行3DDCEMRA108次,二维(2D)DCEMRA10次。
- Index of bore of portal vein was lower in treatment group than that in control group after treatment (P < 0.01). 治疗组治疗后门静脉内径明显小于对照组(P<0.;05)。